Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Oct 18.
Published in final edited form as: Contraception. 2018 Apr 18:S0010-7824(18)30145-8. doi: 10.1016/j.contraception.2018.04.009

The intrauterine device as emergency contraception: how much do young women know?,☆☆

Suzan R Goodman a,*, Alison M El Ayadi a, Corinne H Rocca a, Julia E Kohn b, Courtney E Benedict b, Jessica R Dieseldorff c, Cynthia C Harper a
PMCID: PMC6546552  NIHMSID: NIHMS1030837  PMID: 29679591

Abstract

Background:

Unprotected intercourse is common, especially among teens and young women. Access to intrauterine device (IUD) as emergency contraception (EC) can help interested patients more effectively prevent unintended pregnancy and can also offer ongoing contraception. This study evaluated young women’s awareness of IUD as EC and interest in case of need.

Study design:

We conducted a secondary analysis of data from young women aged 18–25 years, not desiring pregnancy within 12 months, and receiving contraceptive counseling within a cluster-randomized trial in 40 US Planned Parenthood health centers in 2011–2013 (n=1500). Heath centers were randomized to receive enhanced training on contraceptive counseling and IUD placement, or to provide standard care. The intervention did not focus specifically on IUD as EC. We assessed awareness of IUD as EC, desire to learn more about EC and most trusted source of information of EC among women in both intervention and control groups completing baseline and 3- or 6-month follow-up questionnaires (n=1138).

Results:

At follow-up, very few young women overall (7.5%) visiting health centers had heard of IUD as EC. However, if they needed EC, most (68%) reported that they would want to learn about IUDs in addition to EC pills, especially those who would be very unhappy to become pregnant (adjusted odds ratio [aOR], 1.3; 95% confidence interval, 1.0–1.6, p<.05). Most (91%) reported a doctor or nurse as their most trusted source of EC information, over Internet (6%) or friends (2%), highlighting providers’ essential role.

Conclusion:

Most young women at risk of unintended pregnancy are not aware of IUD as EC and look to their providers for trusted information. Contraceptive education should explicitly address IUD as EC.

Implications:

Few young women know that the IUD can be used for EC or about its effectiveness. However, if they needed EC, most reported that they would want to learn about IUDs in addition to EC pills, especially those very unhappy to become pregnant. Contraceptive education should explicitly address IUD as EC.

Keywords: Intrauterine device as emergency contraception, IUD, Emergency contraceptive, Contraceptive, Long-acting reversible contraception, Contraceptive knowledge

1. Background

Unprotected intercourse is common in the United States, as is unintended pregnancy, especially among young women (18–25 years) [1]. Requests for emergency contraception (EC) provide a unique and time-sensitive opportunity to prevent an unwanted pregnancy, as well as to offer ongoing contraception [2]. However, EC remains underutilized, with 23% of sexually experienced teen females reporting ever use [3]. The limited research about EC knowledge among teens and young women suggests that many are poorly informed [4,5]. One study of uninsured teens and young women showed that many were under the false impression that EC had to be taken within 1 day of unprotected sex (44%) and incorrectly identified EC pills (ECPs) as regular birth control (40%), or an abortion pill (40%) [5].

The provider visit is an important time to offer counseling on the full range of contraceptive methods, including the intrauterine device (IUD), which is unfamiliar to many young women [6,7]. For patients to access the IUD, including for EC, a visit with a clinician trained in placement is required, and clinic flow must allow for adequate appointment time. Thus, accessing the IUD as EC is more challenging than oral ECPs with prescription or over-the-counter availability. However, the copper IUD (Cu-IUD) as EC has significantly higher efficacy than ECPs while offering ongoing contraceptive protection [8,9]. In addition, its efficacy remains high in circumstances where ECPs may be less effective, including among obese patients [10], those in the fertile window [2,10] and those with repeat episodes of unprotected intercourse within the five-day window [8].

Nevertheless, provider awareness and provision of IUD as EC remains low, restricting women’s access. Among contraceptive providers in a state family planning program where Food and Drug Administration-approved contraceptives were available at no cost to low-income women, most providers (85%) had never recommended the IUD for EC to patients [11]. Similarly, only 16% of obstetrician-gynecologists nationally reported ever providing the IUD for EC [12]. A multispecialty survey showed that knowledge of IUD as EC is far lower among providers who see, but do not focus on, reproductive-aged women; for example, 84% of reproductive health providers had heard of IUD as EC compared to only 32% of pediatricians and 22% of emergency room providers [13]. Clinic-level access to IUD as EC is also limited; a mystery caller study in 9 US cities found that 49% of family planning clinics offered the IUD as EC, while only 14% of obstetrician-gynecologists and 3% of primary care clinics did so [14].

However, studies suggest that women would be interested in using the IUD as EC, were they to have the knowledge and access [1517]. A study in Utah family planning clinics found that over one-third of women seeking EC would be interested in a contraceptive method that was long term, highly effective and reversible, and 13% would be interested in the IUD as EC [16]. A study in Pittsburgh showed that 15% of women seeking EC or pregnancy testing (12%) were interested in same-day IUD placement [17].

There is a gap in the scientific literature, however, showing nationally whether young women at risk of pregnancy are aware of the IUD as EC and how much they learn in contraceptive counseling. In this analysis of a national trial of young women at clinic visits, we investigated their knowledge and interest in the IUD as EC.

2. Methods

We conducted a post hoc secondary analysis of data from a cluster-randomized trial in 40 Planned Parenthood health centers across the United States in 2011–2013. Health centers were randomly assigned to receive a 4-h evidence-based training intervention (N=20) on patient-centered contraceptive counseling skills, long-acting reversible contraception (LARC) and IUD placement, described in full elsewhere [18], or to provide standard care (N=20). In brief, the training intervention emphasized patient-centered counseling with shared decision making, LARC-specific ethical issues, integration of same-day LARC access into clinical practice and technical assistance for LARC reimbursement. Importantly, the intervention did not focus specifically on the IUD as EC. Standard care varied but was guided by a shared set of evidence-based contraceptive protocols.

Eligible health centers had 400 or more annual contraceptive patients, <20% IUD and implant use among eligible patients, no current LARC-specific intervention program and no staff shared with another study site. The health centers served young and low-income women from diverse racial/ethnic groups. These 40 study sites were distributed across 15 states covering all four Census Bureau-defined regions, and women were recruited at general reproductive health and abortion visits. All clinicians and staff at intervention sites underwent training (over 250 staff). The study was registered at ClinicalTrials.gov (NCT01360216).

The trial enrolled 1500 women (intervention n=802, control n= 698) who met the following criteria at presentation to a study site: aged 18–25 years, at risk of pregnancy (sexually active within the 3 previous months and not pregnant), receiving contraceptive counseling and not desiring pregnancy within 12 months. Patient clinic visit included contraceptive counseling, in the context of gynecologic or abortion care. Participants completed a baseline survey assessing sociodemographics, prior contraceptive use (coded as any use and most effective method used within 3 months prior to baseline) and awareness of contraceptive methods. Participants were followed for 1 year, completing surveys quarterly by phone or online. This study was approved by both University of California, San Francisco, Committee on Human Research and Allendale Investigational Review Board.

2.1. Measures

We evaluated two primary outcomes for IUD as EC: awareness of the IUD as a form of EC and interest in learning about IUD as EC if needed. Our surveys defined emergency contraceptive pill as “morning after pill or Plan B.” The measure of participant awareness of IUD as an EC method was based on the survey item, “Have you ever heard of using an IUD after unprotected sex for emergency contraception?” (yes/no). Interest in learning about IUD as EC was measured with the item “If you needed emergency contraception, would you want to learn about the IUD in addition to the morning after pill?” (yes/no). Three-month surveys asked about having heard of IUD as a form of EC, desire to learn more about IUD as EC and the participants’ most trusted source of information regarding EC; for those missing the 3-month survey, these questions were administered at 6 months. We also asked participants about the effectiveness of the IUD compared to emergency contraceptive pills (more, less, equal, don’t know), as well as their most trusted sources of information about EC at follow-up (a doctor or nurse, friends, the Internet or other source).

Baseline covariates were selected based on association with contraceptive knowledge in prior research [18]. They included age, race/ethnicity (self-identified white, Latina, black or other), insurance type (private, Medicaid/state, none, don’t know), history of pregnancy, currently has primary partner (yes vs. casual/no partner), pregnancy attitudes (very unhappy if became pregnant within 12 months vs. unhappy, happy, or very happy), unprotected intercourse in the last 3 months and practice setting (contraceptive vs. abortion). We also included study arm to examine and account for possible differences in outcomes between patients at intervention vs. control clinics.

2.2. Analyses

Our analysis population comprised participants completing the 3-month survey, or 6-month survey if they had not responded to the 3-month survey and were not missing responses to either of two outcome variables (n=1138). We described overall prevalence of two IUD as EC outcomes: whether they had heard of IUD as EC, and if they needed EC, whether they would want to learn about the IUD. We assessed differences in participant knowledge and perceptions of IUD as EC by each baseline covariable using logistic regression with generalized estimating equations (GEE) to account for the clustered study design, reporting robust standard errors. We repeated analyses using multivariable logistic regression with GEE to assess adjusted effects [18]. To examine the effect that attrition might have had on results, we compared the baseline characteristics of the full sample of participants who were included vs. not included in analyses. All analyses were conducted in Stata v14 (StataCorp, College Station, TX, USA). Differences were considered statistically significant at p<.05.

3. Results

Of the 1500 trial participants at baseline, 915 completed the items of interest as part of the 3-month survey and an additional 263 completed the items of interest as part of the 6-month survey (those who had not completed the 3-month survey), for a total of 1178. Of these 1178,40 were missing responses to either of the outcome variables, leaving 1138 in the analyses, producing a 76% completion rate for the IUD as EC outcomes.

Participants had a mean age of 21.5 years (SD 2.2), and most had never been married (94%) (Table 1). While 31% had public health insurance and 26% had private insurance, 38% reported having no health insurance. Most participants reported a current primary sexual partner (82%), having been previously pregnant (57%) and having had unprotected sex in the last 3 months (64%). Within 3 months prior to baseline, 8% had used ECPs and 3% had used an IUD for contraception. Within the 3 months prior to baseline, the most effective contraceptive method participants reported having used was IUD (3%); implant (1%); injection (8%); pill, patch or ring (42%); condom, other barrier method, or EC (27%); or none (20%); only 8% reported any ECP use during this time period. Sociodemographic characteristics did not differ between the intervention and control groups

Table 1.

Participant characteristics at baseline (n=1138)

n %

Age, mean (SD), years 21.5 (2.2)
Race/ethnicity
 White 571 50.2
 Latina 310 27.2
 Black 159 14.0
 Other 98 8.6
Currently married (n=1131) 65 5.8
Educational attainment (n=1132)
 Less than high school 68 6.0
 Completed high school 737 65.1
 Some college 160 14.1
 College degree 167 14.8
Health insurance type
 Private 300 26.4
 Medicaid/State 348 30.6
 None 437 38.4
 Don’t know 53 4.7
Current primary sexual partner (n=1124) 923 82.1
Ever pregnant ( n=1136) 643 56.6
Any unprotected sex past 3 months (n=1133) 726 64.1
Very unhappy if pregnant next 12 months (n=1134) 476 42.0
Most effective contraception used, prior 3 months (n=1133)
 IUD 33 2.9
 Implant 11 1.0
 Injection 85 7.5
 Pill, patch or ring 477 42.1
 Condom, other barrier method, or EC 305 26.9
 None 222 19.6
Any use of EC past 3 months (n=1133) 93 8.2
Study arm
 Intervention 623 54.7
 Control 515 45.3
Practice setting
 Family planning 682 59.9
 Abortion 456 40.1

Note: no differences in baseline characteristics by study arm were identified.

While most participants at baseline had heard of ECPs (86%) and the IUD (77%), awareness of the IUD as an EC method at follow-up was extremely low, with only 7.5% (n=85) having ever heard of using the IUD as EC (Table 2). Of those few who had heard of IUD as EC, less than half, 48%, (n=41) correctly reported that IUD is more effective than ECP. Nevertheless, over two-thirds (68%) of participants reported that if they needed EC in the future, they would want to learn about IUD in addition to ECP. The vast majority of participants (91%) reported that a doctor or nurse was their most trusted source of information about EC, with the Internet (6%) or friends (2%) considerably lower as the next most trusted sources (Table 2).

Table 2.

Participant knowledge and perceptions of IUD as EC at baseline and follow-up (n=1138)

n %

Baseline
Heard of IUD (n=1133) 876 77.3
Heard of ECP (n=1133) 973 85.9
Follow-up
Heard of IUD as EC 85 7.5
If needed EC, would want to learn about IUD 773 67.9
Familiarity with IUD (n=1135)
 Not at all 213 18.8
 Sort of 464 40.9
 Familiar 458 40.4
Most trusted source of information about EC (n=1134)
 Doctor or nurse 1035 91.3
 Internet 62 5.5
 Friends 21 1.9
 Other 16 1.4

Note: no differences in the above characteristics were identified by study arm.

Multivariable analyses identified no factors associated with having heard of the IUD as EC at follow-up, including study arm (Table 3). Among all factors examined, the only one associated with interest in learning about IUD as EC was being very unhappy to become pregnant in the next 12 months (aOR, 1.26; 95% CI, 1.01–1.58; p=.04). For both primary outcomes (whether they had heard of IUD as EC, and if they needed EC, whether they would want to learn about the IUD), there were no significant differences by factors that might influence need for EC, including recent unprotected intercourse, current primary sexual partner, age or insurance status.

Table 3.

Predictors of knowledge and attitudes of the IUD as EC at follow-up (n=1138)

Baseline characteristics Heard of IUD for EC If needed EC, would
want to learn about IUD


aORa 95% CIb p aORa 95% CIb p

Age 0.95 (0.84,1.07) 0.42 0.95 (0.89,1.01) 0.12
Race/ethnicity
 White Ref - - Ref - -
 Latina 1.22 (0.77–1.92) 0.40 0.97 (0.75–1.26) 0.83
 Black 1.41 (0.81–2.46) 0.23 1.34 (0.96–1.87) 0.08
 Other 1.55 (0.72–3.35) 0.27 1.30 (0.88–1.93) 0.19
Insurance status
 No insurance Ref - - Ref -
 Medicaid/state 1.17 (0.67–2.06) 0.58 0.81 (0.56–1.18) 0.28
 Private 0.74 (0.36–1.52) 0.42 1.05 (0.76–1.46) 0.77
 Don’t know 0.77 (0.24–2.42) 0.65 1.06 (0.56–2.01) 0.87
Ever pregnant 1.47 (0.70–3.08) 0.31 0.93 (0.61–1.42) 0.74
Used LARC, past 3 months 1.08 (0.35–3.37) 0.90 0.83 (0.39–1.77) 0.63
Unprotected sex, past 3
 months 0.97 (0.55–1.71) 0.91 0.94 (0.75–1.18) 0.59
Currently has primary
 sexual partner 0.92 (0.47–1.81) 0.80 0.98 (0.70–1.37) 0.91
Very unhappy if pregnant,
 next 12 months 1.31 (0.83–2.06) 0.24 1.26 (1.01–1.58) 0.04
Study arm
 Control Ref - - Ref - -
 Intervention 0.97 (0.71–1.32) 0.855 0.93 (0.67–1.30) 0.69
Practice setting
 Family planning Ref - - Ref - -
 Abortion site 0.97 (0.63–1.49) 0.895 1.23 (0.82–1.85) 0.32
a

aOR = adjusted odds ratio.

b

CI = confidence interval.

The analytic population did not differ from those missing the 3- or 6-month assessments in the trial (n= 362) in terms of age, race, pregnancy intention, study arm or prior 3-month emergency contraceptive use.

4. Discussion

In this 40-site US study of sexually active young women, very few had heard of the IUD as a form of EC or knew of its significantly higher efficacy compared to ECPs, but most would desire to learn about it if they needed EC. The desire to learn about the IUD as EC was especially notable for those who would be very unhappy if they were to become pregnant in the next 12 months, suggesting that enhanced education about immediate and ongoing effectiveness of the IUD could be of great benefit to them. Furthermore, our results emphasized the important role of health care providers as the primary trusted source of information about EC for young women, followed far behind by the Internet or friends.

The majority of young women enrolled in our study reported awareness of ECPs, in contrast to past reports where this knowledge was less common [4], demonstrating important gains made through initiatives to increase ECP access for women of all ages [19]. However, the low proportion of women in our study reporting having heard of the IUD as EC, less than 10%, highlights the importance of presenting the IUD as the form of EC that also offers ongoing contraceptive protection in patient education. Women needing immediate EC generally have a strong desire to prevent pregnancy [20], and studies show that those using IUD as EC were significantly more likely to be using an IUD or other effective method at 6 months [21], and less likely to have an unintended pregnancy in the next year compared to those who use ECPs [2,13].

Updated guidelines advise that women needing immediate EC should be counseled by pharmacists or frontline staff to see providers trained in IUD placement in order to facilitate the full range of EC options [22,23]. One study found that adolescents and young women who had heard of the IUD from a health care provider were 2.7 times more likely to be interested in this method for contraception [6]. This finding accentuates the need to overcome logistical challenges of rapid access or referral within the appropriate time window after unprotected intercourse.

Actionable steps to improve access to IUD as EC have been demonstrated in various trials. An effort to educate pharmacists and improve rapid access referral increased the uptake of IUD as EC nearly threefold in one study [24]. A pilot study in nine family planning clinics showed that clinics were able to accommodate 77% of patients desiring IUD as EC as same-day placements, while the remaining patients returned for placement within the 5-day window after unprotected intercourse [25]. Salient changes included clinic staff training, updated EC educational materials and counseling scripts offering same-day IUD among EC options. Additional operational changes included schedule templates with walk-in availability, benefit verification early in the visit, expanded staff roles to complete counseling, consent and IUD set up and immediate access (or rapid referral) to clinicians trained in IUD placement [25,26]. Further progress may be achieved through use of online educational materials, clinician proctoring programs, swift conversion of patient no-shows to walk-in appointments, improved patient cycle times and tightened networks to assure timely referral when this service is not immediately available.

Additional IUD as EC options are under evaluation. A promising prospective trial evaluating use of the levonorgestrel (LNG) IUD along with concomitant oral LNG ECP vs. Cu-IUD as EC showed that participants preferentially chose the LNG IUD plus ECPs, neither group had treatment failures, and both had similar 1-year continuation rates [27,28].

With the preference-sensitive nature of contraceptive decisions [2931], providers should be versed in the range of EC methods and their advantages, while remaining focused on rapport and patient priorities in their counseling. Research shows that establishing rapport and eliciting patient perspective are associated with higher satisfaction and contraceptive continuation [31]. Salient among reported patient preferences is the ability to control when to start and stop a contraceptive method [29,32], with various studies reinforcing the importance that IUD provision come with the assurance of removal when requested and mention of the option of IUD self-removal [33,34].

Strengths of this study include a real-world clinic environment among patients at risk of unintended pregnancy, within Planned Parenthood health centers, which provide contraceptive information and services for over 2 million patients annually [35]. Our study also had limitations. Our observed lack of association between awareness of IUD as EC and study arm suggests an opportunity to more explicitly address IUD as EC in contraceptive provider training. The study intervention itself did not specifically target this IUD indication. Results may not be generalizable to all settings that provide EC such as pharmacies, primary care clinics or emergency departments, where knowledge, staff training and same-day access to IUD as EC are often lower.

In conclusion, we found that few young women know about IUD as EC or its effectiveness, and that they consider health care providers to be their most trusted source for this information. Contraceptive information from a trusted provider can have significant impact on a patient’s decision making and should include all available options, while also remaining focused on patient priorities [36]. A coordinated effort to improve counseling, provider training and same-day access to IUD as EC will be critical to offering women their full range of contraceptive options.

Acknowledgments

The study was funded by the William and Flora Hewlett Foundation. We thank the UCSF Bixby Center research team for data collection and management. We thank Johanna Morfesis, Lisa Stern, Dr. Vanessa Cullins, Dr. Ashlesha Patel (all at PPFA and without conflicts) and Planned Parenthood investigators and research coordinators at these affiliates: Northern, Central and Southern New Jersey; Columbia Willamette; Great Northwest and the Hawaiian Islands; Greater Ohio; Greater Washington and North Idaho; Mar Monte; Michigan; Minnesota, North Dakota, South Dakota; Mt. Baker; Northern California; Pacific Southwest; Pasadena and San Gabriel Valley; Rocky Mountains; South Atlantic; Southeastern Pennsylvania; Southern New England; and Southwest and Central Florida. All these contributors received compensation. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of Planned Parenthood Federation of America, Inc. Units for intervention training in IUD placement were provided by Teva Pharmaceuticals Industries and Bayer HealthCare.

☆☆ Funding: This study was funded by the William and Flora Hewlett Foundation. Support was also received from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Office of Research on Women’s Health, Building Interdisciplinary Research Careers in Women’s Health (Grant K12 HD052163 and the NICHD (Grant K99HD086232). These entities had no role in study design, interpretation, decision to submit or writing.

Footnotes

Disclosure: Julia Kohn and Courtney Benedict declare that their institution, Planned Parenthood Federation of America, participates in studies sponsored by HRA Pharma that are unrelated to this study.

All other authors report no conflict of interest.

References

  • [1].Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med 2016;374(9):843–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Turok DK, Jacobson JC, Dermish AI, Simonsen SE, Gurtcheff S, McFadden SM, et al. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Contraception 2014;89(3):222–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Abma JC, Martinez GM. Sexual activity and contraceptive use among teenagers in the US, 2011–2015. Ntl Health Stat Rep 2017;104. [PubMed] [Google Scholar]
  • [4].Ahern R, Frattarelli L, Delto J, Kaneshiro B. Knowledge and awareness of emergency contraception in adolescents. J Pediatr Adolesc Gynecol 2010;23:273–8. [DOI] [PubMed] [Google Scholar]
  • [5].Yen S, Parmar D, Lin E, Ammerman S. Emergency contraception pill awareness and knowledge in uninsured adolescents: high rates of misconceptions concerning indications for use, side effects, and access.J Pediatr Adolesc Gynecol 2015;28:337–42. [DOI] [PubMed] [Google Scholar]
  • [6].Fleming KL, Sokoloff A, Raine TR. Attitudes and beliefs about the intrauterine device among teenagers and young women. Contraception 2010;82:178–82.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Whitaker AK, Johnson LM, Harwood B, Chiappetta L, Creinin MD, Gold MA. Adolescent and young adult women’s knowledge of and attitudes toward the intrauterine device. Contraception 2008;78(3):211–7. [DOI] [PubMed] [Google Scholar]
  • [8].Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 2012;27(7):1994–2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Cheng L, Che Y, Gulmezoglu AM. Interventions for emergency contraception. Cochrane Database Syst Rev 2012;15(8). [DOI] [PubMed] [Google Scholar]
  • [10].Glasier A, Cameron ST, Blithe D, Scherrer B, Mathe H, Levy D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011;84(4):363. [DOI] [PubMed] [Google Scholar]
  • [11].Harper CC, Speidel JJ, Drey EA, Trussell J, Blum M, Darney PD. Copper intrauterine device for emergency contraception: clinical practice among contraceptive providers. Obstet Gynecol 2012;119(2 Pt1):220–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Luchowski AT, Anderson BL, Power ML, Raglan GB, Espey E, Schulkin J. Obstetrician-gynecologists and contraception: practice and opinions about the use of IUDs in nulliparous women, adolescents and other patient populations. Contraception 2014;89(6):572–7. [DOI] [PubMed] [Google Scholar]
  • [13].Batur P, Cleland K, McNamara M, Wu J, Pickle S, EC Survey Group. Emergency contraception: a multispecialty survey of clinician knowledge and practices. Contraception 2016;93(2):145–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Schubert FD, Bisop ES, Gold M. Access to the copper IUD as post-coital contraception: results from a mystery caller study. Contraception 2016;94(5):561–6. [DOI] [PubMed] [Google Scholar]
  • [15].Edwards C, Panjwani D, Pendrith C, Ly A, Dunn S. Knowledge of and interest in the copper intrauterine device among women seeking emergency contraception. J Obstet Gynaecol Can 2017;40(1):41–7 [pii: S1701–2163(17)30441–3]. [DOI] [PubMed] [Google Scholar]
  • [16].Turok DK, Gurtcheff SE, Handley E, Simonsen SE, Sok C, North R, et al. A survey of women obtaining emergency contraception: are they interested in using copper IUD? Contraception 2011;83(5):441–6. [DOI] [PubMed] [Google Scholar]
  • [17].Schwarz EB, Kavanaugh M, Douglas E, Dubowitz T, Creinin MD. Interest in intrauterine contraception among seekers of emergency contraception and pregnancy testing. Obstet Gynecol 2009;113(4):833–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Harper CC, Rocca CH, Thompson KM, Morfesis J, Goodman S, Darney PD, et al. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. Lancet 2015;386(9993):562–8. [DOI] [PubMed] [Google Scholar]
  • [19].Raine TR, Ricciotti N, Sokoloff A, Brown Ba, Hummel A, Harper CC. An over-the-counter simulation study of a single tablet emergency contraceptive in young females. Obstet Gynecol 2012;119:1–8. [DOI] [PubMed] [Google Scholar]
  • [20].Royer PA, Turok DK, Sanders JN, Saltzman HM. Choice of emergency contraceptive and decision making regarding subsequent unintended pregnancy. J Womens Health (Larchmt) 2016;25(10):1038–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Envall N, Groes Kofoed N, Kopp-Kallner H. Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate—a prospective observational cohort study. Acta Obstet Gynecol Scand 2016;95(8):887–93. [DOI] [PubMed] [Google Scholar]
  • [22].ACOG Practice Bulletin, Number 152; 2015. [Emergency Contraception]. [Google Scholar]
  • [23].US selected practice recommendations for contraceptive use, MMWR Recomm Rep 2016;65(4):1–66. [DOI] [PubMed] [Google Scholar]
  • [24].Clement KM, Mansour DJ. Improving uptake of the copper intrauterine device for emergency contraception by educating pharmacists in the community. J Fam Plann Reprod Health Care 2014;40(1):41–5. [DOI] [PubMed] [Google Scholar]
  • [25].Kohn JE, Nucatola DL. EC4U: results from a pilot project integrating the copper IUC into emergency contraceptive care. Contraception 2016;94(1):48–51. [DOI] [PubMed] [Google Scholar]
  • [26].EC4U Toolkit. Planned Parenthood Federation of America; 2014. [Google Scholar]
  • [27].Turok DK, Sanders JN, Thompson IS, Royer PA, Eggebroten J, Gawron LM. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study. Contraception 2016;93(6):526–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Sanders JN, Turok DK, Royer PA, Thompson IS, Gawron LM, Storck KE. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception. Contraception 2017;96(2):99–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Jackson AV, Karasek D, Dehlendorf C, Foster DG. Racial and ethnic differences in women’s preferences for features of contraceptive methods. Contraception 2016; 93(5):406–11. [DOI] [PubMed] [Google Scholar]
  • [30].Donnelly KZ, Foster TC, Thompson R. What matters most? The content and concordance of patients’ and providers’ information priorities for contraceptive decision making. Contraception 2014;90(3):280–7. [DOI] [PubMed] [Google Scholar]
  • [31].Dehlendorf C, Henderson JT, Vittinghoff E, Grumbach K, Levy K, Schmittdiel J, et al. Association of the quality of interpersonal care during family planning counseling with contraceptive use.AmJ Obstet Gynecol 2016;215(1):78.e1–9. [DOI] [PubMed] [Google Scholar]
  • [32].Lessard LN, Karasek D, Ma S, Darney PD, Deardorff J, Lahiff M, et al. Contraceptive features preferred by women at high risk of unintended pregnancy. Perspect Sex Reprod Health 2012;44(3):194–200. [DOI] [PubMed] [Google Scholar]
  • [33].Amico JR, Bennett AH, Karasz A, Gold M. “I wish they could hold on a little longer”: physicians’ experiences with requests for early IUD removal. Contraception 2017;96(2):106–10. [DOI] [PubMed] [Google Scholar]
  • [34].Foster DG, Grossman D, Turok DK, Peipert JF, Prine L, Schreiber CA, et al. Interest in and experience with IUD self-removal. Contraception 2014;90(1):54–9. [DOI] [PubMed] [Google Scholar]
  • [35].Planned Parenthood Federation of America. PPFAAnnual Report 2015–2016. https://www.plannedparenthood.org/uploads/filer_public/18/40Z1840b04b-55d3-4c00-959d-11817023ffc8/20170526_annualreport_p02_singles.pdf.
  • [36].Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol 2014;57(4):659–73. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES